A Wealth of Experience

We have collaborated with our clients on projects to research hematology, hematologic treatments, and complications and comorbidities of hematologic diseases. Our experience includes:

  • Allogeneic cord blood therapy 
  • Anemia
  • Blood transfusions
  • Hemophilia A
  • Hemophilia B
  • Myelofibrosis
  • Neutropenia
  • Polycythemia Vera
  • Pulmonary and venous embolism
  • Thrombocytopenia

Types of Projects

We have implemented studies to help our clients develop strategies in the hematology market and to develop and gain 
market access for products to treat hematologic diseases and complications arising from treatment of hematologic diseases.

Recent projects have included:

Our Experts

Annete Njue
Senior Director, Market Access and Outcomes Strategy
Lynda Doward
European Head, Patient-Centered Outcomes Assessment
Sorrel Wolowacz
Head, European Health Economics
James Kaye
Senior Director, Epidemiology
Kati Copley-Merriman
Vice President, Market Access and Outcomes Strategy
Isobel Pearson
Senior Director, Health Economics, Health Technology Assessment
William L Herring
Senior Director, Health Economics
Anne Heyes
Vice President, Head Market Access and Outcomes Strategy, Europe
Shahnaz Khan
Executive Director, Market Access and Outcomes Strategy
Caroline Ling
Executive Director and HTA Specialist, Market Access and Outcomes Strategy
Alicia Gilsenan
Senior Director and Head, Epidemiology
Jin Yang
Associate Director, Market Access and Outcomes Strategy
Maria Fernandez
Senior Director, Market Access and Outcomes Strategy
Dana DiBenedetti
Executive Director, Patient-Centered Outcomes Assessment
Keith Davis
Senior Director, Health Economics
Chris Knight
Senior Director, Health Economics
Lia Gutierrez
Senior Director, Epidemiology
Xiaolei Zhou
Director, Biostatistics
Joan Fortuny
Director, Epidemiology

Selected Recent Hematology Publications